Staff Publications: March 2016

Andrake MD, Skalka AM. Retroviral Integrase: Then and Now. Annu Rev Virol. 2015;2(1):241-264.

Azadarmaki R, Then MT, Walia R, Lango MN. Cavernous hemangioma of the submandibular gland with parapharyngeal extension in an adult: Case report. Ear Nose Throat J. 2016;95(2):E11-13.

Battistuzzi FU, Billing-Ross P, Murillo O, Filipski A, Kumar S. A Protocol for Diagnosing the Effect of Calibration Priors on Posterior Time Estimates: A Case Study for the Cambrian Explosion of Animal Phyla. Mol Biol Evol. 2015;32(7):1907-1912.

Beck TN, Golemis EA, Geynisman DM. Reply to Francesco Piva, Matteo Santoni, Marina Scarpelli, et al’s Letter to the Editor re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4. Eur Urol. 2016.

Boikos SA, Pappo AS, Killian JK, et al. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic. JAMA Oncol. 2016.

Boland PM, Meyer JE, Berger AC, et al. Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection. Am J Clin Oncol. 2016.

Boscoe FP, Henry KA, Sherman RL, Johnson CJ. The relationship between cancer incidence, stage, and poverty in the United States. Int J Cancer. 2016.

Budina-Kolomets A, Webster MR, Leu JI, et al. HSP70 inhibition limits FAK-dependent invasion and enhances the response to melanoma treatment with BRAF inhibitors. Cancer Res. 2016.

Chan JK, Brady MF, Penson RT, et al. Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer. N Engl J Med. 2016;374(8):738-748.

Churilla T, Egleston B, Dong Y, et al. Disparities in the management and outcome of cervical cancer in the United States according to health insurance status. Gynecol Oncol. 2016.

Davis BM, Rall GF, Schnell MJ. Everything You Always Wanted to Know About Rabies Virus (But Were Afraid to Ask). Annu Rev Virol. 2015;2(1):451-471.

Di Marcantonio D, Galli D, Carubbi C, et al. PKCepsilon as a novel promoter of skeletal muscle differentiation and regeneration. Exp Cell Res. 2015;339(1):10-19.

Dmitrieva OS, Shilovskiy IP, Khaitov MR, Grivennikov SI. Interleukins 1 and 6 as main mediators of inflammation and cancer. Biochemistry-Moscow. 2016;81(2):80-90.

Dong Y, Li T, Churilla TM, et al. Effects of Time to Treatment on Biochemical and Clinical Outcomes for Patients With Prostate Cancer Treated With Definitive Radiation. Clin Genitourin Cancer. 2016.

Dotan E, Alpaugh RK, Ruth K, et al. Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma. Pancreas. 2016.

Dunning AM, Michailidou K, Kuchenbaecker KB, et al. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nat Genet. 2016;48(4):374-386.

Ettinger DS, Wood DE, Akerley W, et al. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016. J Natl Compr Canc Netw. 2016;14(3):255-264.

Haas NB, Manola J, Uzzo RG, et al. Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial. Lancet. 2016.

Jacobs AS, Schwartz MD, Valdimarsdottir H, et al. Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer. Fam Cancer. 2016.

Kadariya Y, Menges CW, Talarchek J, et al. Inflammation-Related IL-1beta/IL-1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma. Cancer Prev Res (Phila). 2016.

Khalili K, Kaminski R, Gordon J, Cosentino L, Hu W. Genome editing strategies: potential tools for eradicating HIV-1/AIDS. J Neurovirol. 2015;21(3):310-321.

Kim DW, Mehra R, Tan DS, et al. Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial. Lancet Oncol. 2016.

Kung CP, Khaku S, Jennis M, Zhou Y, Murphy ME. Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes. Mol Cancer Res. 2015;13(2):250-262.

Li F, Li W, Li X, et al. Geniposide Attenuates Inflammatory Response by Suppressing P2Y Receptor and Downstream ERK1/2 Signaling Pathway in Oxygen and Glucose Deprivation-induced Brain Microvascular Endothelial Cells. J Ethnopharmacol. 2016.

Li YF, Ren LN, Guo G, et al. Endothelial progenitor cells in ischemic stroke: an exploration from hypothesis to therapy. J Hematol Oncol. 2015;8:33.

Meyer JE, Dilling TJ, Amdur RJ, et al. In regard to Wu and Vapiwala et al [Letter]. Int J Radiat Oncol Biol Phys. 2016;94(4):858-859.

Nghiem VT, Davies KR, Beck JR, Follen M, Cantor SB. Overtreatment and cost-effectiveness of the see-and-treat strategy for managing cervical precancer. Cancer Epidemiol Biomarkers Prev. 2016.

Olszanski AJ, Smith DC, Camacho LH, et al. Electrocardiographic Characterization of Ramucirumab on the Corrected QT Interval in a Phase II Study of Patients With Advanced Solid Tumors. Oncologist. 2016.

O’Malley DM, Hudson SV, Ohman-Strickland PA, et al. Follow-up Care Education and Information: Identifying Cancer Survivors in Need of More Guidance. Journal of Cancer Education. 2016;31(1):63-69.

Reddy PN, Radu M, Xu K, et al. P21 activated kinase 2 regulates HSPC cytoskeleton, migration and homing via CDC42 activation and interaction with beta-Pix. Blood. 2016.

Ristau BT, Cahn D, Uzzo RG, Chapin BF, Smaldone MC. The role of radical prostatectomy in high-risk localized, node-positive and metastatic prostate cancer. Future Oncology. 2016;12(5):687-699.

Shaikh T, Churilla TM, Monpara P, Scott WJ, Cohen SJ, Meyer JE. Risk of radiation pneumonitis in patients receiving taxane-based trimodality therapy for locally advanced esophageal cancer. Pract Radiat Oncol. 2016.

Shaikh T, Li T, Murphy CT, et al. Importance of Surgical Margin Status in Ductal Carcinoma In Situ. Clin Breast Cancer. 2016.

Tammaro M, Liao SR, Beeharry N, Yan H. DNA double-strand breaks with 5 ‘ adducts are efficiently channeled to the DNA2-mediated resection pathway. Nucleic Acids Research. 2016;44(1):221-231.

Thunnissen E, Blaauwgeers HJ, de Cuba EM, Yick CY, Flieder DB. Ex Vivo Artifacts and Histopathologic Pitfalls in the Lung. Arch Pathol Lab Med. 2016;140(3):212-220.

Wang HH, Cui YL, Zaorsky NG, et al. Mesenchymal stem cells generate pericytes to promote tumor recurrence via vasculogenesis after stereotactic body radiation therapy. Cancer Lett. 2016.

Zaorsky NG, Keith SW, Shaikh T, et al. Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities. Am J Clin Oncol. 2016.

Zibelman M, Mehra R. Overview of Current Treatment Options and Investigational Targeted Therapies for Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Am J Clin Oncol. 2016.

Zibelman M, Plimack ER. Checkpoint Inhibitors and Urothelial Carcinoma: The Translational Paradigm. Oncology-New York. 2016;30(2):160-+.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s